Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 278

1.

Immunogenicity of rat-neu+ mouse mammary tumours determines the T cell-dependent therapeutic efficacy of anti-neu monoclonal antibody treatment.

Sow HS, Benonisson H, Brouwers C, Linssen MM, Camps M, Breukel C, Claassens J, van Hall T, Ossendorp F, Fransen MF, Verbeek JS.

Sci Rep. 2020 Mar 3;10(1):3933. doi: 10.1038/s41598-020-60893-8.

2.

Growth rate assays reveal fitness consequences of β-lactamases.

Santiago F, Doscher E, Kim J, Camps M, Meza J, Sindi S, Barlow M.

PLoS One. 2020 Jan 31;15(1):e0228240. doi: 10.1371/journal.pone.0228240. eCollection 2020.

3.

Heavy chain dimers stabilized by disulfide bonds are required to promote in vitro assembly of trastuzumab.

Farràs M, Román R, Camps M, Miret J, Martínez Ó, Pujol X, Casablancas A, Cairó JJ.

BMC Mol Cell Biol. 2020 Jan 21;21(1):2. doi: 10.1186/s12860-019-0244-x.

4.

Aquaglyceroporins Are Differentially Expressed in Beige and White Adipocytes.

da Silva IV, Díaz-Sáez F, Zorzano A, Gumà A, Camps M, Soveral G.

Int J Mol Sci. 2020 Jan 17;21(2). pii: E610. doi: 10.3390/ijms21020610.

5.

Homogeneous antibody-drug conjugates: DAR 2 anti-HER2 obtained by conjugation on isolated light chain followed by mAb assembly.

Farràs M, Miret J, Camps M, Román R, Martínez Ó, Pujol X, Erb S, Ehkirch A, Cianferani S, Casablancas A, Cairó JJ.

MAbs. 2020 Jan-Dec;12(1):1702262. doi: 10.1080/19420862.2019.1702262.

6.

A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control.

Tondini E, Arakelian T, Oosterhuis K, Camps M, van Duikeren S, Han W, Arens R, Zondag G, van Bergen J, Ossendorp F.

Oncoimmunology. 2019 Sep 2;8(11):1652539. doi: 10.1080/2162402X.2019.1652539. eCollection 2019.

7.

Effective chemoimmunotherapy by co-delivery of doxorubicin and immune adjuvants in biodegradable nanoparticles.

Da Silva CG, Camps MGM, Li TMWY, Zerrillo L, Löwik CW, Ossendorp F, Cruz LJ.

Theranostics. 2019 Aug 21;9(22):6485-6500. doi: 10.7150/thno.34429. eCollection 2019.

8.

Co-delivery of immunomodulators in biodegradable nanoparticles improves therapeutic efficacy of cancer vaccines.

Da Silva CG, Camps MGM, Li TMWY, Chan AB, Ossendorp F, Cruz LJ.

Biomaterials. 2019 Nov;220:119417. doi: 10.1016/j.biomaterials.2019.119417. Epub 2019 Aug 7.

PMID:
31419588
9.

PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors.

Beyrend G, van der Gracht E, Yilmaz A, van Duikeren S, Camps M, Höllt T, Vilanova A, van Unen V, Koning F, de Miranda NFCC, Arens R, Ossendorp F.

J Immunother Cancer. 2019 Aug 14;7(1):217. doi: 10.1186/s40425-019-0700-3.

10.

Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton's Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases.

Caldwell RD, Qiu H, Askew BC, Bender AT, Brugger N, Camps M, Dhanabal M, Dutt V, Eichhorn T, Gardberg AS, Goutopoulos A, Grenningloh R, Head J, Healey B, Hodous BL, Huck BR, Johnson TL, Jones C, Jones RC, Mochalkin I, Morandi F, Nguyen N, Meyring M, Potnick JR, Santos DC, Schmidt R, Sherer B, Shutes A, Urbahns K, Follis AV, Wegener AA, Zimmerli SC, Liu-Bujalski L.

J Med Chem. 2019 Sep 12;62(17):7643-7655. doi: 10.1021/acs.jmedchem.9b00794. Epub 2019 Aug 15.

PMID:
31368705
11.

The microstructure in the placenta is influenced by the functional diversity of HLA-G allelic variants.

Stieglitz F, Celik AA, von Kaisenberg C, Camps MA, Blasczyk R, Bade-Döding C.

Immunogenetics. 2019 Jul;71(7):455-463. doi: 10.1007/s00251-019-01121-0. Epub 2019 Jun 27.

12.

Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models.

Haselmayer P, Camps M, Liu-Bujalski L, Nguyen N, Morandi F, Head J, O'Mahony A, Zimmerli SC, Bruns L, Bender AT, Schroeder P, Grenningloh R.

J Immunol. 2019 May 15;202(10):2888-2906. doi: 10.4049/jimmunol.1800583. Epub 2019 Apr 15.

13.

Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models.

Sow HS, Ren J, Camps M, Ossendorp F, Ten Dijke P.

Cells. 2019 Apr 5;8(4). pii: E320. doi: 10.3390/cells8040320.

14.

Neuregulin 4 Is a Novel Marker of Beige Adipocyte Precursor Cells in Human Adipose Tissue.

Comas F, Martínez C, Sabater M, Ortega F, Latorre J, Díaz-Sáez F, Aragonés J, Camps M, Gumà A, Ricart W, Fernández-Real JM, Moreno-Navarrete JM.

Front Physiol. 2019 Jan 31;10:39. doi: 10.3389/fphys.2019.00039. eCollection 2019.

15.

Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication.

Zom GG, Willems MMJHP, Khan S, van der Sluis TC, Kleinovink JW, Camps MGM, van der Marel GA, Filippov DV, Melief CJM, Ossendorp F.

J Immunother Cancer. 2018 Dec 12;6(1):146. doi: 10.1186/s40425-018-0455-2.

16.

Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy.

Fransen MF, Schoonderwoerd M, Knopf P, Camps MG, Hawinkels LJ, Kneilling M, van Hall T, Ossendorp F.

JCI Insight. 2018 Dec 6;3(23). pii: 124507. doi: 10.1172/jci.insight.124507.

17.

Arming oncolytic reovirus with GM-CSF gene to enhance immunity.

Kemp V, van den Wollenberg DJM, Camps MGM, van Hall T, Kinderman P, Pronk-van Montfoort N, Hoeben RC.

Cancer Gene Ther. 2019 Sep;26(9-10):268-281. doi: 10.1038/s41417-018-0063-9. Epub 2018 Nov 23.

PMID:
30467340
18.

Effect of continuous feeding of CO2 and pH in cell concentration and product titers in hIFNγ producing HEK293 cells: Induced metabolic shift for concomitant consumption of glucose and lactate.

Román R, Farràs M, Camps M, Martínez-Monge I, Comas P, Martínez-Espelt M, Lecina M, Casablancas A, Cairó JJ.

J Biotechnol. 2018 Dec 10;287:68-73. doi: 10.1016/j.jbiotec.2018.10.005. Epub 2018 Oct 21.

PMID:
30352245
19.

FcγR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor model.

Sow HS, Benonisson H, Breukel C, Visser R, Verhagen OJHM, Bentlage AEH, Brouwers C, Claassens JWC, Linssen MM, Camps M, van Hall T, Ossendorp F, Fransen MF, Vidarsson G, Verbeek JS.

Int J Cancer. 2019 Jan 15;144(2):345-354. doi: 10.1002/ijc.31899. Epub 2018 Nov 12.

20.

Caveolar targeting links Kv1.3 with the insulin-dependent adipocyte physiology.

Pérez-Verdaguer M, Capera J, Ortego-Domínguez M, Bielanska J, Comes N, Montoro RJ, Camps M, Felipe A.

Cell Mol Life Sci. 2018 Nov;75(21):4059-4075. doi: 10.1007/s00018-018-2851-7. Epub 2018 Jun 11.

PMID:
29947924
21.

Genetic control of ColE1 plasmid stability that is independent of plasmid copy number regulation.

Standley MS, Million-Weaver S, Alexander DL, Hu S, Camps M.

Curr Genet. 2019 Feb;65(1):179-192. doi: 10.1007/s00294-018-0858-0. Epub 2018 Jun 16.

22.

Chemical Control over T-Cell Activation in Vivo Using Deprotection of trans-Cyclooctene-Modified Epitopes.

van der Gracht AMF, de Geus MAR, Camps MGM, Ruckwardt TJ, Sarris AJC, Bremmers J, Maurits E, Pawlak JB, Posthoorn MM, Bonger KM, Filippov DV, Overkleeft HS, Robillard MS, Ossendorp F, van Kasteren SI.

ACS Chem Biol. 2018 Jun 15;13(6):1569-1576. doi: 10.1021/acschembio.8b00155. Epub 2018 May 11.

23.

Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.

Ho NI, Camps MGM, de Haas EFE, Ossendorp F.

Eur J Immunol. 2018 Jul;48(7):1164-1173. doi: 10.1002/eji.201747372. Epub 2018 May 17.

24.

A Restricted Role for FcγR in the Regulation of Adaptive Immunity.

Fransen MF, Benonisson H, van Maren WW, Sow HS, Breukel C, Linssen MM, Claassens JWC, Brouwers C, van der Kaa J, Camps M, Kleinovink JW, Vonk KK, van Heiningen S, Klar N, van Beek L, van Harmelen V, Daxinger L, Nandakumar KS, Holmdahl R, Coward C, Lin Q, Hirose S, Salvatori D, van Hall T, van Kooten C, Mastroeni P, Ossendorp F, Verbeek JS.

J Immunol. 2018 Apr 15;200(8):2615-2626. doi: 10.4049/jimmunol.1700429. Epub 2018 Mar 9.

25.

Network Analysis of Protein Adaptation: Modeling the Functional Impact of Multiple Mutations.

Beleva Guthrie V, Masica DL, Fraser A, Federico J, Fan Y, Camps M, Karchin R.

Mol Biol Evol. 2018 Jun 1;35(6):1507-1519. doi: 10.1093/molbev/msy036.

26.

Hollow microneedle-mediated micro-injections of a liposomal HPV E743-63 synthetic long peptide vaccine for efficient induction of cytotoxic and T-helper responses.

van der Maaden K, Heuts J, Camps M, Pontier M, Terwisscha van Scheltinga A, Jiskoot W, Ossendorp F, Bouwstra J.

J Control Release. 2018 Jan 10;269:347-354. doi: 10.1016/j.jconrel.2017.11.035. Epub 2017 Nov 22.

27.

Fluorescence-Based Reporters for Detection of Mutagenesis in E. coli.

Standley M, Allen J, Cervantes L, Lilly J, Camps M.

Methods Enzymol. 2017;591:159-186. doi: 10.1016/bs.mie.2017.03.013. Epub 2017 Jun 9.

28.

C1q-Dependent Dendritic Cell Cross-Presentation of In Vivo-Formed Antigen-Antibody Complexes.

Ho NI, Camps MGM, de Haas EFE, Trouw LA, Verbeek JS, Ossendorp F.

J Immunol. 2017 Jun 1;198(11):4235-4243. doi: 10.4049/jimmunol.1602169. Epub 2017 Apr 21.

29.

PTPN22 is not associated with Behçet's disease. Study spanning the complete gene region in the Spanish population and meta-analysis of the functional variant R620W.

Ortiz-Fernández L, Montes-Cano MA, García-Lozano JR, Conde-Jaldón M, Ortego-Centeno N, González-Leon R, Espinosa G, Graña-Gil G, Sánchez-Bursón J, Juliá MR, Solans R, Blanco R, Barnosi-Marín AC, Fanlo P, Rodríguez Carballeira M, Camps MT, Castañeda S, Martín J, González-Escribano MF.

Clin Exp Rheumatol. 2016 Sep-Oct;34(6 Suppl 102):S41-S45. Epub 2016 Apr 1.

PMID:
27050764
30.

Strong in vivo antitumor responses induced by an antigen immobilized in nanogels via reducible bonds.

Li D, Sun F, Bourajjaj M, Chen Y, Pieters EH, Chen J, van den Dikkenberg JB, Lou B, Camps MG, Ossendorp F, Hennink WE, Vermonden T, van Nostrum CF.

Nanoscale. 2016 Dec 1;8(47):19592-19604.

PMID:
27748778
31.

Oral Drugs Related with Muscle Wasting and Sarcopenia. A Review.

Campins L, Camps M, Riera A, Pleguezuelos E, Yebenes JC, Serra-Prat M.

Pharmacology. 2017;99(1-2):1-8. doi: 10.1159/000448247. Epub 2016 Aug 31. Review.

32.

Loss-of-Function Mutations in ELMO2 Cause Intraosseous Vascular Malformation by Impeding RAC1 Signaling.

Cetinkaya A, Xiong JR, Vargel İ, Kösemehmetoğlu K, Canter Hİ, Gerdan ÖF, Longo N, Alzahrani A, Camps MP, Taskiran EZ, Laupheimer S, Botto LD, Paramalingam E, Gormez Z, Uz E, Yuksel B, Ruacan Ş, Sağıroğlu MŞ, Takahashi T, Reversade B, Akarsu NA.

Am J Hum Genet. 2016 Aug 4;99(2):299-317. doi: 10.1016/j.ajhg.2016.06.008. Epub 2016 Jul 28.

33.

Diazotrophs: a non-negligible source of nitrogen for the tropical coral Stylophora pistillata.

Benavides M, Houlbrèque F, Camps M, Lorrain A, Grosso O, Bonnet S.

J Exp Biol. 2016 Sep 1;219(Pt 17):2608-12. doi: 10.1242/jeb.139451. Epub 2016 Jun 22.

34.

Virological surveillance of influenza and other respiratory viruses during six consecutive seasons from 2006 to 2012 in Catalonia, Spain.

Antón A, Marcos MA, Torner N, Isanta R, Camps M, Martínez A, Domínguez A, Jané M, Jiménez de Anta MT, Pumarola T.

Clin Microbiol Infect. 2016 Jun;22(6):564.e1-9. doi: 10.1016/j.cmi.2016.02.007. Epub 2016 Mar 2.

35.

Caveolin interaction governs Kv1.3 lipid raft targeting.

Pérez-Verdaguer M, Capera J, Martínez-Mármol R, Camps M, Comes N, Tamkun MM, Felipe A.

Sci Rep. 2016 Mar 2;6:22453. doi: 10.1038/srep22453.

36.

Neuregulin improves response to glucose tolerance test in control and diabetic rats.

López-Soldado I, Niisuke K, Veiga C, Adrover A, Manzano A, Martínez-Redondo V, Camps M, Bartrons R, Zorzano A, Gumà A.

Am J Physiol Endocrinol Metab. 2016 Mar 15;310(6):E440-51. doi: 10.1152/ajpendo.00226.2015. Epub 2015 Dec 29.

37.

Poor Muscle Strength and Low Physical Activity Are the Most Prevalent Frailty Components in Community-Dwelling Older Adults.

Papiol M, Serra-Prat M, Vico J, Jerez N, Salvador N, Garcia M, Camps M, Alpiste X, López J.

J Aging Phys Act. 2016 Jul;24(3):363-8. doi: 10.1123/japa.2015-0114. Epub 2015 Nov 3.

PMID:
26540738
38.

Lipopolysaccharide binding protein is an adipokine involved in the resilience of the mouse adipocyte to inflammation.

Moreno-Navarrete JM, Escoté X, Ortega F, Camps M, Ricart W, Zorzano A, Vendrell J, Vidal-Puig A, Fernández-Real JM.

Diabetologia. 2015 Oct;58(10):2424-34. doi: 10.1007/s00125-015-3692-7. Epub 2015 Jul 23.

PMID:
26201685
39.

Mechanisms of Theta Plasmid Replication.

Lilly J, Camps M.

Microbiol Spectr. 2015 Feb;3(1):PLAS-0029-2014. doi: 10.1128/microbiolspec.PLAS-0029-2014. Review.

PMID:
26104556
40.

Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.

Rosendahl Huber SK, Camps MG, Jacobi RH, Mouthaan J, van Dijken H, van Beek J, Ossendorp F, de Jonge J.

PLoS One. 2015 Jun 5;10(6):e0127969. doi: 10.1371/journal.pone.0127969. eCollection 2015.

41.

Mechanisms of Theta Plasmid Replication.

Lilly J, Camps M.

Microbiol Spectr. 2015 Feb;3(1). pii: PLAS-0029-2014.

42.

The timing and spatiotemporal patterning of Neanderthal disappearance.

Higham T, Douka K, Wood R, Ramsey CB, Brock F, Basell L, Camps M, Arrizabalaga A, Baena J, Barroso-Ruíz C, Bergman C, Boitard C, Boscato P, Caparrós M, Conard NJ, Draily C, Froment A, Galván B, Gambassini P, Garcia-Moreno A, Grimaldi S, Haesaerts P, Holt B, Iriarte-Chiapusso MJ, Jelinek A, Jordá Pardo JF, Maíllo-Fernández JM, Marom A, Maroto J, Menéndez M, Metz L, Morin E, Moroni A, Negrino F, Panagopoulou E, Peresani M, Pirson S, de la Rasilla M, Riel-Salvatore J, Ronchitelli A, Santamaria D, Semal P, Slimak L, Soler J, Soler N, Villaluenga A, Pinhasi R, Jacobi R.

Nature. 2014 Aug 21;512(7514):306-9. doi: 10.1038/nature13621.

PMID:
25143113
43.

Enhanced cross-presentation and improved CD8+ T cell responses after mannosylation of synthetic long peptides in mice.

Rauen J, Kreer C, Paillard A, van Duikeren S, Benckhuijsen WE, Camps MG, Valentijn AR, Ossendorp F, Drijfhout JW, Arens R, Burgdorf S.

PLoS One. 2014 Aug 19;9(8):e103755. doi: 10.1371/journal.pone.0103755. eCollection 2014.

44.

Mechanisms of plasmid segregation: have multicopy plasmids been overlooked?

Million-Weaver S, Camps M.

Plasmid. 2014 Sep;75:27-36. doi: 10.1016/j.plasmid.2014.07.002. Epub 2014 Aug 7. Review.

45.

Random mutagenesis by error-prone pol plasmid replication in Escherichia coli.

Alexander DL, Lilly J, Hernandez J, Romsdahl J, Troll CJ, Camps M.

Methods Mol Biol. 2014;1179:31-44. doi: 10.1007/978-1-4939-1053-3_3.

46.

Efficient induction of antitumor immunity by synthetic toll-like receptor ligand-peptide conjugates.

Zom GG, Khan S, Britten CM, Sommandas V, Camps MG, Loof NM, Budden CF, Meeuwenoord NJ, Filippov DV, van der Marel GA, Overkleeft HS, Melief CJ, Ossendorp F.

Cancer Immunol Res. 2014 Aug;2(8):756-64. doi: 10.1158/2326-6066.CIR-13-0223. Epub 2014 Apr 21.

47.

Antifouling coatings influence both abundance and community structure of colonizing biofilms: a case study in the Northwestern Mediterranean Sea.

Camps M, Barani A, Gregori G, Bouchez A, Le Berre B, Bressy C, Blache Y, Briand JF.

Appl Environ Microbiol. 2014 Aug;80(16):4821-31. doi: 10.1128/AEM.00948-14. Epub 2014 Jun 6.

48.

Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies.

Haselmayer P, Camps M, Muzerelle M, El Bawab S, Waltzinger C, Bruns L, Abla N, Polokoff MA, Jond-Necand C, Gaudet M, Benoit A, Bertschy Meier D, Martin C, Gretener D, Lombardi MS, Grenningloh R, Ladel C, Petersen JS, Gaillard P, Ji H.

Front Immunol. 2014 May 22;5:233. doi: 10.3389/fimmu.2014.00233. eCollection 2014.

49.

A gold coordination compound as a chemical probe to unravel aquaporin-7 function.

Madeira A, de Almeida A, de Graaf C, Camps M, Zorzano A, Moura TF, Casini A, Soveral G.

Chembiochem. 2014 Jul 7;15(10):1487-94. doi: 10.1002/cbic.201402103. Epub 2014 May 28.

PMID:
24891084
50.

Human aquaporin-11 is a water and glycerol channel and localizes in the vicinity of lipid droplets in human adipocytes.

Madeira A, Fernández-Veledo S, Camps M, Zorzano A, Moura TF, Ceperuelo-Mallafré V, Vendrell J, Soveral G.

Obesity (Silver Spring). 2014 Sep;22(9):2010-7. doi: 10.1002/oby.20792. Epub 2014 May 21.

Supplemental Content

Support Center